Pixofisiran (sodium)
Pixofisiran sodium is a siRNA in STP705. It targets to TGF‐β1. STP705 is composed of 2 siRNA oligonucleotides (Pixofisiran and Lixadesiran) that individually target TGF-β1 and COX-2 mRNA.
Product Specifications
UNSPSC
12352208
Target
TGF-β Receptor
Related Pathways
TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[Pixofisiran(sodium)]
References & Citations
[1]Nestor MS, Hetzel J, Awad N, Bhupalam V, Lu P, Molyneaux M. A Novel Injectable Polypeptide Nanoparticle Encapsulated siRNA Targeting TGF-β1 and COX-2 for Localized Fat Reduction II: Phase I Clinical Trial. J Cosmet Dermatol. 2025;24 (2) :e16722.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E3220-01E-PE 100 µL
Enkephalin, Leu (Leu Enkephalin, Leu-Enkephalin, Opioid Growth Factor, OGF, Proenkephalin, PENK, Proenkephalin A, Proenkephalin B, PENKB, Synenkephalin) (PE) discontinued
Ask
View Details 
GTR15345737 1 Vial
Lentiviral human COP1 shRNA (UAS) - Lentiviral human COP1 shRNA (UAS, iRFP) (25)
Ask
View Details 
